New York, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global revenue from the perfusion bioreactors market is estimated to reach US$ 345.6 Million in 2022, with the global market growing at a 7.2% CAGR to ...
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...
Recombinant adeno-associated virus (rAAV) is currently used as vector in about 250 clinical trials for gene therapy (Bulcha et al., 2021). Nonetheless, there are still several challenges concerning ...
Fed-batch gives you one data point per sample pull. Perfusion demands continuous, real-time process intelligence, and process analytical technology (PAT) is the only way to deliver it. As ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
Bench-Scale Bioreactors Incorporate Single-Use Elements, Linearly Scalable Actuators, and Sensors Bench-scale bioreactors ranging in volume from about 2 L to 20 L have become indispensable as ...
Single-use Bioreactors Market worth $9.58 billion by 2031 - Exclusive Report by MarketsandMarkets™
The impact of customer-side business trends in the single-use bioreactors market is shaped by changing biomanufacturing priorities, process intensification, and demand for flexible production capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results